Monitoring of antibiotic resistance of gram negative anaerobes;Surveillance de la résistance aux antibiotiques des anaérobies stricts à Gram négatif

Medecine et Maladies Infectieuses

Volumn 38, Issue 5, 2008, Pages 256-263

  Singer, E ^a   Calvet, L ^a   Mory, F ^b   Muller, C ^c   Chomarat, M ^d   Bezian M C ^e   Bland, S ^f   Juvenin, M E ^g   Drugeon, H ^g   Fosse, T ^h   Goldstein, F ⁱ   Jaulhac, B ^j   Monteil, H ^j   Marchandin, H ^k   Jean Pierre, H ^k   Dubreuil, L ^a  

^a UNIV LILLE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c BICHAT HOSPITAL   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e HÔPITAL SAINT ANDRÉ   (France)

^f Centre Hospitalier de la Region d'Annecy   (France)

^g HÔTEL DIEU   (France)

^h CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

ⁱ SAINT JOSEPH HOSPITAL   (France)

^j UNIVERSITÉ DE STRASBOURG   (France)

^k HÔPITAL ARNAUD DE VILLENEUVE   (France)

more..

Author keywords

Antibiotic resistance; Gram negative anaerobes

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOXITIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TIMENTIN;

AGAR DIFFUSION; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTEROIDES; BACTEROIDES FRAGILIS; CONTROLLED STUDY; FUSOBACTERIUM; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PORPHYROMONAS; PREVOTELLA; VEILLONELLA;

ABDOMEN; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE AEROBIC RODS AND COCCI; HUMANS; SKIN;

EID: 44749088147     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2008.03.007     Document Type: Article

References (26)

1. Behra-Miellet J., Calvet L., Mory F., Muller C., Chomarat M., Bézian M.C., et al. Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a french multicentric survey. Anaerobe 9 (2003) 105-111
2. Dubreuil L., Breuil J., and Dublanchet A. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992. Eur J Clin Microbiol Infect Dis 11 (1992) 1094-1099
3. Grollier G., Mory F., Quentin C., Girard-Pipau F., Tigaud S., Sedallian A., et al. Survey of anaerobic susceptibility patterns: a French multicentric study. Path Biol 42 (1994) 498-504
4. Bland S., Sedaillan A., Grollier G., Mory F., Houcke I., and Dubreuil L. In vitro activity of three carbapenems biapenem, imipenem and meropenem and some other antibiotics against anaerobic bacteria. Path Biol 43 (1995) 289-293
5. Mory F., Loczniewski A., Bland S., Sedallian A., Grollier G., Girard-Pipau F., et al. Survey of anaerobic susceptibility patterns: a French multicentric study. Int J Antimicrob Agents 10 (1998) 229-236
6. Dubreuil L., Singer E., Jaulhac B., Mory F., Lozniewski A., Bland S., et al. Sensibilité des anaérobies stricts aux antibiotiques. Antibiotiques 1 (1999) 147-153
7. Dublanchet A., Caillon J., Emond J.P., Chardon H., and Drugeon H.B. Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles. Eur J Clin Microbiol 5 (1986) 346-347
8. Dubreuil L., Behra-Miellet J., Vouillot C., Bland S., Sedallian A., and Mory F. ß-lactamase production in Prevotella and in vitro susceptibilities to selected beta-lactam antibiotics. Int J Antimicrob Agents 21 (2003) 267-273
9. Sandoe J.A.T., Struthers J.K., and Brazier J.S. Subdural empyema caused by Prevotella loescheii with reduced susceptibility to metronidazole. J Antimicrob Chemother 47 (2001) 366-367
10. Summanen P., Baron E.J., Citron D.M., Strong C.A., Wexler H.M., and Finegold S.M. Wadsworth anaerobic bacteriology manual. 5th ed. (1993), Star Publishing Co., Belmont, California
11. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard. 5th ed. NCCLS document M11-A5. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA [ISBN 1-56238-429-5].
12. Ericsson H.M., and Sherris J.C. Antibiotic sensitivity testing: report of an international collaborative study. Acta Pathol Microbiol Scand Sect B 27 (1971) 1-90
13. Comité de l'Antibiogramme de la Société Française de Microbiologie. Report 2003. Int J Antimicrob Agents 2003; 21: 364-91.
14. Rasmussen B.A., Gluzman Y., and Tally F.P. Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636. Antimicrob Agents Chemother 34 8 (1990) 1590-1592
15. Thompson J.S., and Malamy M.H. Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus beta-lactamase II. J Bacteriol 172 5 (1990) 2584-2593
16. Podglajen I., Breuil J., Bordon F., Gutmann L., and Collatz E. A silent carbapenemase gene in strains of Bacteroides fragilis can be expressed after a one-step mutation. FEMS Microbiol Lett 70 1 (1992) 21-29
17. Rogers M.B., Bennett T.K., Payne C.M., and Smith C.J. Insertional activation of cepA leads to high-level beta-lactamase expression in Bacteroides fragilis clinical isolates. J Bacteriol 176 14 (1994) 4376-4384
18. Odou M.F., Singer E., Romond M.B., and Dubreuil L. Isolation and characterization of a porin-like protein of 45 kilodaltons from Bacteroides fragilis. FEMS Microbiol Lett 166 2 (1998) 347-354
19. Parker A.C., and Smith C.J. Genetic and biochemical analysis of a novel Ambler class A beta-lactamase responsible for cefoxitin resistance in Bacteroides species. Antimicrob Agents Chemother 37 5 (1993) 1028-1036
20. Dubreuil L, Houcke E, Singer E, Bryskier A. Comparative activity of Faropenem and other antimicrobial agents against 462 clinical anaerobes. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Toronto, Ontario, Canada; 1997. Abstract F 222.
21. Elsaguier A.A.F., Brazier J.S., and James E.A. Bacteremia due to Bacteroides fragilis with reduced susceptibility to metronidazole. J Antimicrob Chemother 51 (2003) 1436-1437
22. Gal M., and Brazier J.S. Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazole-resistant mutants. J Antimicrob Chemother 54 1 (2004) 109-116
23. Schaumann R., Petzold S., Fille M., and Rodloff A.C. Inducible metronidazole resistance in nim-positive and nim-negative Bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates. Infection 33 5-6 (2005) 368-372
24. e éd. (2006), Edts Eska, Paris 521-536
25. Löfmark S., Fang H., Hedberg M., and Edlund C. Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates. Antimicrob Agents Chemother 49 3 (2005) 1253-1256
26. Mory F., Carlier J.P., Alauzet C., Thouvenin M., Schuhmacher H., and Lozniewski A. Bacteremia caused by a metronidazole-resistant Prevotella sp. strain. J Clin Microbiol 43 10 (2005) 5380-5383